Evidence map›Paper›PMID 24346350›Full record

ArticleNature communications2013

Effectors of animal and plant pathogens use a common domain to bind host phosphoinositides.

Dor Salomon, Yirui Guo, Lisa N Kinch, Nick V Grishin, Kevin H Gardner, Kim Orth

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Overexpression ofPlant signaling & behavior · 2025
    Article
  4. Atomic Structure and Phospholipid Binding Properties of thebioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Type III Secretion 1 Effector Gene Diversity AmongFrontiers in cellular and infection microbiology · 2020
    Article
  16. Interactions of the effector ExoU fromThe Journal of biological chemistry · 2019
    Article
  17. Article
  18. Article
  19. Review
  20. The Role of Proteases in the Virulence of Plant Pathogenic Bacteria.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dor SalomonDepartment of Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9148, USA.
Yirui GuoDepartment of Biophysics and Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8816, USA.
Lisa N KinchHoward Hughes Medical Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9050, USA.
Nick V Grishin1] Department of Biophysics and Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8816, USA [2] Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9050, USA.
Kevin H GardnerDepartment of Biophysics and Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8816, USA.
Kim OrthDepartment of Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9148, USA.
The University of Texas Southwestern Medical Center · USSouthwestern Medical Center · US

Funding

Biochemical Characterization of Yersinia Effector YopJ.R01AI056404 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI ORTH, KIM · 2003 to 2012
$2.8M
Computational methods for structural-functional studies of proteinsR01GM094575 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI GRISHIN, NICK V. · 2010 to 2017
$2.4M
Structural studies of PAS domain signaling mechanismsR01GM081875 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI GARDNER, KEVIN H · 2007 to 2010
$1.2M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI056404NIAID NIH HHS R01-AI056404NIGMS NIH HHS GM094575NIGMS NIH HHS R01 GM081875NIGMS NIH HHS R01-GM081875NIGMS NIH HHS R01 GM094575
6 · The paper itself

Abstract

Bacterial Type III Secretion Systems deliver effectors into host cells to manipulate cellular processes to the advantage of the pathogen. Many host targets of these effectors are found on membranes. Therefore, to identify their targets, effectors often use specialized membrane-localization domains to localize to appropriate host membranes. However, the molecular mechanisms used by many domains are unknown. Here we identify a conserved bacterial phosphoinositide-binding domain (BPD) that is found in functionally diverse Type III effectors of both plant and animal pathogens. We show that members of the BPD family functionally bind phosphoinositides and mediate localization to host membranes. Moreover, NMR studies reveal that the BPD of the newly identified Vibrio parahaemolyticus Type III effector VopR is unfolded in solution, but folds into a specific structure upon binding its ligand phosphatidylinositol-(4,5)-bisphosphate. Thus, our findings suggest a possible mechanism for promoting refolding of Type III effectors after delivery into host cells.

Indexed as

Bacterial Secretion SystemsAgrobacterium tumefaciensAmino Acid SequenceBacterial ProteinsCell MembraneChloroplastsEscherichia coliGene DeletionGreen Fluorescent ProteinsHeLa CellsHumansLigandsMembrane ProteinsMolecular Sequence DataPhosphatidylinositolsProtein BindingBacterial ProteinsBacterial Secretion SystemsGreen Fluorescent ProteinsLigandsMembrane ProteinsPhosphatidylinositols

Identifiers

PMID24346350
PMCPMC4981085
OpenAlexW2021130283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.